Tolerogenic vaccines for the treatment of cardiovascular diseases

by Fernando Lozano Vigario, Johan Kuiper, Bram Slütter
Published 2020-07-01

PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.

by Chantal Keijzer, Bram Slütter, Ruurd van der Zee, Wim Jiskoot, Willem van Eden, Femke Broere
Published 2011-01-01

Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates

by Deborah M. B. Post, Bram Slutter, Birgit Schilling, Aroon T. Chande, Jed A. Rasmussen, Bradley D. Jones, Alexandria K. D’Souza, Lorri M. Reinders, John T. Harty, Bradford W. Gibson, Michael A. Apicella, Edward G. Ruby
Published 2017-10-01

Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis

by Eva Kritikou, Marie A.C. Depuydt, Margreet R. de Vries, Kevin E. Mulder, Arthur M. Govaert, Marrit D. Smit, Janine van Duijn, Amanda C. Foks, Anouk Wezel, Harm J. Smeets, Bram Slütter, Paul H.A. Quax, Johan Kuiper, Ilze Bot
Published 2019-04-01